Prolight Diagnostics recently participated at the 2024 Cardiac Markers Dialogue Meeting in Glasgow, UK. This meeting brought together leading researchers and healthcare professionals specializing in cardiology and cardiac biomarker-based diagnostics.
“We showcased our innovative point-of-care platform, Psyros, to aid rapid diagnosis of myocardial infarction, while engaging in discussions on the latest advancements in the field”, said Prolight’s CSO, Dr. Aileen McGettrick.
Read the full article at biostock.se:
https://www.biostock.se/en/2024/10/point-of-care-in-the-spotlight-at-cardiac-markers-dialogue-meeting/
This is a press release from BioStock – Connecting Innovation & Capital. https://www.biostock.se
